Drugs / Xintong Oral Liquid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07088523 | Jul 2025 → Dec 2026 expected | diabetes mellitus, ischemic disease | Guangzhou University of Traditional Chinese Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xintong Oral Liquid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07088523 ↗ |
| Route | Oral | “10 mL tid po from week 5 to 52.” NCT07088523 ↗ |